What is happening, page-3185

with respect Mallyrock, do you think adding another product line helps.

To me this seems to be getting a bit scatter gun if this is how AXE is going to go forward. Managing all this to a commercial result is not a walk in the park.

Meanwhile in latest newsletter which I got this morning, Mo is off on another WEF conflab in May in San Fran. Maybe, hopefully someone accosts him in a corridor and says 'we want to partner'

In the podcast that kamantea shared, Mo says what keeps him up at night is if Australia will lose its quantum strategical lead to the world. Wondering if any one has a view on what the priorities of AXE are. It sounds like Mo is still busy positioning us strategically on some map that he has in his head. That's all good, but it won't translate to a re rate until commercial value is more obvious.

Anyhow I am long term very chipper about AXE mallyrock. Some re rate into the $3 to $5 is possible with bio chip news for a start. For me, that's the starting pistol